Edition:
United States

Health News

Photo

Trump's drug czar nominee withdraws from consideration 12:49pm EDT

WASHINGTON President Donald Trump's pick for U.S. drug czar withdrew on Tuesday after it become public that he spearheaded a bill that undercut the government's power to crack down on opioid makers that were flooding the market with the addictive painkillers. | Video

More Headlines

Fatty liver disease fastest-growing reason for transplants in young U.S. adults

(Reuters Health) - Nonalcoholic fatty liver disease and its more aggressive form, nonalcoholic steatohepatitis, have become the fastest-growing reasons for liver transplants in young Americans, according to a recent study.

12:21pm EDT

Drugmakers Amneal, Impax to combine in generics push

Amneal Pharmaceuticals LLC is buying peer Impax Laboratories Inc in an all-stock deal as it looks to add heft to its generics business and gain an edge in a tough drug pricing environment.

Deals, Drug Pricing 9:54am EDT
Photo

Japan's "Blade Library" offers joy of blade running to amputees

TOKYO Haruta Saito, a young Japanese amputee who dreams of becoming a Paralympian, remembers strapping on a prosthetic "running blade" for the first time.

Japan 4:21am EDT
Photo

Trump says he could jettison drug czar pick

WASHINGTON U.S. President Donald Trump said on Monday he would review a report that his nominee for drug czar championed a law that weakened the government's ability to fight the nation's opioid epidemic, and said he could consider jettisoning the pick.

Politics, Election 2016, Oct 16 2017

Health Watch Graphics